APA (7th ed.) Citation

Leone, C., Di Stefano, G., Di Pietro, G., Bloms-Funke, P., Boesl, I., Caspani, O., . . . Treede, R. (2022). IMI2-PainCare-BioPain-RCT2 protocol: A randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activity. Current controlled trials in cardiovascular medicine, 23(1), 739-26. https://doi.org/10.1186/s13063-022-06431-5

Chicago Style (17th ed.) Citation

Leone, Caterina, et al. "IMI2-PainCare-BioPain-RCT2 Protocol: A Randomized, Double-blind, Placebo-controlled, Crossover, Multicenter Trial in Healthy Subjects to Investigate the Effects of Lacosamide, Pregabalin, and Tapentadol on Biomarkers of Pain Processing Observed by Non-invasive Neurophysiological Measurements of Human Spinal Cord and Brainstem Activity." Current Controlled Trials in Cardiovascular Medicine 23, no. 1 (2022): 739-26. https://doi.org/10.1186/s13063-022-06431-5.

MLA (9th ed.) Citation

Leone, Caterina, et al. "IMI2-PainCare-BioPain-RCT2 Protocol: A Randomized, Double-blind, Placebo-controlled, Crossover, Multicenter Trial in Healthy Subjects to Investigate the Effects of Lacosamide, Pregabalin, and Tapentadol on Biomarkers of Pain Processing Observed by Non-invasive Neurophysiological Measurements of Human Spinal Cord and Brainstem Activity." Current Controlled Trials in Cardiovascular Medicine, vol. 23, no. 1, 2022, pp. 739-26, https://doi.org/10.1186/s13063-022-06431-5.